Skip to main content

Discovery of a new mechanism of gene control that is associated with cancer



Press & Communications Section Head
Tel.+34 93 40 37255

Several national and international media, such as Science Daily, have reported on the latest findings by Maria Macias, at IRB Barcelona, and Joan Massagué, adjunct director at IRB Barcelona and researcher at the Memorial Sloan-Kettering Cancer Center. After three years of intensive work, the team of researchers have characterized the life cycle of Smad proteins, essential components in the modulation of cell cycle. These results may prove crucial to develop new clinical therapies against cancer.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).